Article
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.
European journal of cancer care - 1 May 2017
Miaskowski C, Cooper B A, Aouizerat B, Melisko M, Chen L-M, Dunn L, Hu X, Kober K M, Mastick J, Levine J D, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N
Abstract excerpt
Some oncology outpatients experience a higher number of and more severe symptoms during chemotherapy (CTX). However, little is known about whether this high risk phenotype persists over time. Latent transition analysis (LTA) was used to examine the probability that patients remained in the same symptom class when assessed prior to the administration of and following their next dose of CTX. For the patients whose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.